Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 2265Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Leukemia 1500Leukemia, Lymphocytic, Chronic, B-Cell 1120Myelodysplastic Syndromes 963Hematologic Neoplasms 935Lymphoma 739Lymphoma, Non-Hodgkin 654Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Multiple Myeloma 501Lymphoma, Follicular 467Hodgkin Disease 460Lymphoma, Mantle-Cell 459Burkitt Lymphoma 440Lymphoma, Large B-Cell, Diffuse 433Lymphoma, B-Cell, Marginal Zone 402Recurrence 356Leukemia, Myelomonocytic, Chronic 351Myeloproliferative Disorders 330Leukemia, Myeloid, Chronic-Phase 311Lymphoma, Large-Cell, Immunoblastic 303Congenital Abnormalities 273Neoplasms 271Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Blast Crisis 246Leukemia, Myeloid, Accelerated Phase 244Primary Myelofibrosis 221Neoplasms, Plasma Cell 220Waldenstrom Macroglobulinemia 216Lymphoma, T-Cell, Cutaneous 197

Interventions

thymoglobulin 1selinexor 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Chromosome Aberrations × Other hematologic neoplasm × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT02403310 2022-10-03

A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
21 enrolled
Other hematologic neoplasm

Chromosome Aberrations, Leukemia, Leukemia, Myeloid, Acute

NCT05456048 2022-07-13

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Nanfang Hospital, Southern Medical University

Completed
231 enrolled
Other hematologic neoplasm

Chromosome Aberrations, Recurrence, Leukemia, Myeloid, Acute

NCT00461929 2009-02-13

GIST

University Health Network, Toronto

Phase 4 Terminated
68 enrolled
MyeloidOther hematologic neoplasm

Chromosome Aberrations, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡